Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Johnson & Johnson (NY:JNJ)

152.94 +0.33 (+0.22%)
Official Closing Price Updated: 4:10 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Looking At Johnson & Johnson's Recent Unusual Options Activity
Via Benzinga
7 Diversified Income Powerhouses for Lifelong Cash Flow
Explore diversified income stocks that provide stable cash flow and growth potential for long-term investors seeking lifelong income. 
Via InvestorPlace
3 Rock-Solid Income Machines to Hold for Decades
Hitch your ride with these three long-term income stocks with robust dividend yields, proven to boost portfolios with consistent growth 
Via InvestorPlace
3 Dividend Aristocrats Now Cheaper Than During the 2008 Financial Crisis
Explore opportunities in undervalued Dividend Aristocrats, featuring Genuine Parts, Johnson & Johnson, and Archer-Daniels-Midland. 
Via InvestorPlace
What's Going On With Johnson and Johnson Shares Friday?
In the last week, Johnson and Johnson announced positive results from two clinical trials and authorization from Health Canada for RYBREVANT in combination with platinum-based chemotherapy. 
Via Benzinga
Nasdaq vs. Dow Jones: A Detailed Breakdown of Stock Indexes
Nasdaq focuses on tech and growth stocks, offering high returns with higher volatility. Dow covers diverse sectors, providing steadier, lower-risk performance. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Assessing Johnson &amp; Johnson's Performance Against Competitors In Pharmaceuticals Industry
Via Benzinga
Exploring NYSE:JNJ's dividend characteristics.
Analyzing JOHNSON & JOHNSON (NYSE:JNJ)'s Dividend Potential. 
Via Chartmill
FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
Biotech stocks are on the verge of a comeback after a period of underperformance amid a wave of FDA approvals. 
Via InvestorPlace
Exposures Product Safety
Upcoming Stock Spinoffs: Should You Pounce or Pass?
Stock spinoffs are a unique opportunity to pick up unloved, unwanted businesses but patience is often needed before buying in. 
Via InvestorPlace
7 Blue-Chip Cash Cows to Milk for Steady Income
Sometimes, you want to weather the storm rather than risk everything. For that, blue-chip income stocks can help. 
Via InvestorPlace
AbbVie Stock: A Perfect Dip for Investors to Buy
ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investors 
Via MarketBeat
Topics ETFs
7 Safe Haven Stocks to Buy Before the Next Market Correction
Discover resilient safe haven stocks to weather economic fluctuations in restaurants, pharmaceuticals, household products, and retail. 
Via InvestorPlace
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
These Dividend Aristocrats all have payouts yielding three times or more the average yield of the S&P 500. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
Johnson & Johnson announced Phase 3 CARTITUDE-4 study results showing Carvykti significantly improves overall survival in relapsed or lenalidomide-refractory multiple myeloma after one prior line of... 
Via Benzinga
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout. 
Via MarketBeat
Topics ETFs
Exposures COVID-19
Court Rules Against Johnson & Johnson In Talcum Powder Cancer Study Case
A federal judge has dismissed a Johnson & Johnson subsidiary's lawsuit against Dr. Jacqueline Moline, who linked talc products to cancer. The ruling supports Moline's research and free speech rights... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
JNJ Should Rally Soon Or See 3 Swings Higher At Least
Johnson & Johnson (JNJ​​​​​​​) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. 
Via Talk Markets
5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In First Half 2024
Ten of the Dow Jones Industrial Average stocks were up double digit percentage in the first half of 2024. A look at the best and worst performers. 
Via Benzinga
Topics Stocks
Exposures US Equities
"Rule Breaker Investing" Mailbag: Talking Stocks and Options
We also talk with Sean Milliken, managing director of The Motley Fool Foundation’s ImpactFool (IF) Fund. 
Via The Motley Fool
3 Retirement All-Stars for Steady Growth and Income
Retirement stocks lead the pack with steady dividends and strong growth potential. Invest smartly for a worry-free retirement. 
Via InvestorPlace
Topics Retirement
Exposures Pension
3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks
Explore three high-yield dividend stocks that not only offer yields of 3% or more but also boast multiple decades of payout growth. 
Via InvestorPlace
Judge Blocks Cancer Victims' Attempt To Stop Johnson & Johnson Bankruptcy Plan
A federal judge rejected a bid by cancer victims to block Johnson & Johnson from pursuing a $6.48 billion bankruptcy settlement for talc-related lawsuits, stating potential harm was "strictly... 
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
3 Magnificent Stocks Retirees Can Buy and Hold Forever
These stocks could be ideal for investors in their golden years. 
Via The Motley Fool
Boing! 7 Undervalued Stocks That Could Surprise the Skeptics.
The market previously supported a higher multiple for these undervalued stocks, making them attractive contrarian targets. 
Via InvestorPlace
Treasure Hunt: 3 Small-Cap Stocks Wall Street Hasn’t Discovered Yet
Undiscovered small-cap stocks hold the greatest potential for creating investor wealth as they can take off at a moment's notice. 
Via InvestorPlace
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
Income-seeking investors can find plenty of opportunities in any market environment. 
Via The Motley Fool
4 Cheap Stocks to Buy in July
All four of these stocks are trading at very intriguing valuations. 
Via The Motley Fool
10 Blue-Chip Dividend Growth Stocks With 3% Yields And Safe Dividends
A look at 10 blue-chip dividend growth stocks with yields above 3%, the opportunity for those yields to continue growing in the future, and where we can be very certain that the dividend is safe. 
Via Talk Markets
Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600
Protagonist Therapeutics will join the SmallCap 600 on Wednesday. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.